Enbrel Outpaces Humira In The First Three Lines Of Treatment In Newly Diagnosed Rheumatoid Arthritis Patients
Links shared publicly online about this topic.
- 670total visits
Enbrel Outpaces Humira In The First Three Lines Of Treatment In Newly Diagnosed Rheumatoid Arthritis Patients
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amgen/Pfizer's Enbrel is the leading tumor necrosis factor (TNF)-alp
View full resource at medicalnewstoday.com
Tags: Crohn's Disease Medication, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Pharma, Enbrel, Humira
Most Recently Shared on December 8, 2010 at 7:05 pm By:
Enbrel Outpaces Humira In The First Three Lines Of Treatment In Newly Diagnosed Rheumatoid Arthritis Patients http://mnt.to/3NLD #arthritis
Advertisement
